The DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index.
In vitro preclinical evaluation studies with the echinocandin antifungal MK-0991 (L-743,872)
Open accessAbstract
The echinocandin MK-0991, formerly L-743,872, is a water-soluble lipopeptide that has been demonstrated in preclinical studies to have potent activity against Candida spp., Aspergillus fumigatus, and Pneumocystis carinii. An extensive in vitro biological evaluation of MK-0991 was performed to better define the potential activities of this novel compound. Susceptibility testing with MK-0991 against approximately 200 clinical isolates of Candida, Cryptococcus neoformans, and Aspergillus isolates was conducted to determine MICs and minimum fungicidal concentrations MF(s). The MFC at which 90% of isolates are inhibited for 40 C. albicans clinical isolates was 0.5 microg/ml. Susceptibility testing with panels of antifungal agent-resistant species of Candida and C. neoformans isolates indicated that the MK-0991 MFCs for these isolates are comparable to those obtained for susceptible isolates. Growth kinetic studies of MK-0991 against Candida albicans and Candida tropicalis isolates showed that the compound exhibited fungicidal activity (i.e., a 99% reduction in viability) within 3 to 7 h at concentrations ranging from 0.06 to 1 microg/ml (0.25 to 4 times the MIC). Drug combination studies with MK-0991 plus amphotericin B found that this combination was not antagonistic against C. albicans, C. neoformans, or A. fumigatus in vitro. Studies with 0 to 50% pooled human or mouse serum established that fungal susceptibility to MK-0991 was not significantly influenced by the presence of human or mouse serum. Results from resistance induction studies suggested that the susceptibility of C. albicans was not altered by repeated exposure (40 passages) to MK-0991. Erythrocyte hemolysis studies with MK-0991 with washed and unwashed human or mouse erythrocytes indicated minimal hemolytic potential with this compound. These favorable results of preclinical studies support further studies with MK-0991 with humans.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
National Committee for Clinical Laboratory Standards
Bruck, E. (1980) · Pediatrics · doi:10.1542/peds.65.1.187 · Cited by 14,751
Komshian, S. V., Uwaydah, A. K., Sobel, J. D., & Crane, L. R. (1989) · Clinical Infectious Diseases · doi:10.1093/clinids/11.3.379 · Cited by 457
Kurtz, M. B., Heath, I. B., Marrinan, J., Dreikorn, S., Onishi, J., & Douglas, C. (1994) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.38.7.1480 · Cited by 320
New Spectrum of Fungal Infections in Patients with Cancer
Anaissie, E., Bodey, G. P., Kantarjian, H., Ro, J., Vartivarian, S. E., Hopfer, R., Hoy, J., & Rolston, K. (1989) · Clinical Infectious Diseases · doi:10.1093/clinids/11.3.369 · Cited by 259
Ruhnke, M., Eigler, A., Tennagen, I., Geiseler, B., Engelmann, E., & Trautmann, M. (1994) · Journal of Clinical Microbiology · doi:10.1128/jcm.32.9.2092-2098.1994 · Cited by 251
Fluconazole resistance in Candida glabrata
Hitchcock, C. A., Pye, G. W., Troke, P. F., Johnson, E. M., & Warnock, D. W. (1993) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.37.9.1962 · Cited by 244
Collaborative comparison of broth macrodilution and microdilution antifungal susceptibility tests
Espinel-Ingroff, A., Kish, C. W., Kerkering, T. M., Fromtling, R. A., Bartizal, K., Galgiani, J. N., Villareal, K., Pfaller, M. A., Gerarden, T., & Rinaldi, M. G. (1992) · Journal of Clinical Microbiology · doi:10.1128/jcm.30.12.3138-3145.1992 · Cited by 243
Self-citationCompounds active against cell walls of medically important fungi
Hector, R. F. (1993) · Clinical Microbiology Reviews · doi:10.1128/cmr.6.1.1 · Cited by 242
Abruzzo, G. K., Flattery, A. M., Gill, C. J., Kong, L., Smith, J. G., Pikounis, V. B., Balkovec, J. M., Bouffard, A. F., Dropinski, J. F., Rosen, H., et al. (1997) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.41.11.2333 · Cited by 241
Self-citationHospital-acquired infections: diseases with increasingly limited therapies.
Swartz, M. N. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.7.2420 · Cited by 232
Anaissie, E. J., Bodey, G. P., & Rinaldi, M. G. (1989) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/bf01963467 · Cited by 205
Guiot, H. F. L., Fibbe, W. E., & van't Wout, J. W. (1994) · Clinical Infectious Diseases · doi:10.1093/clinids/18.4.525 · Cited by 179
Fluconazole-Resistant Candida albicans
Boken, D. J., Swindells, S., & Rinaldi, M. G. (1993) · Clinical Infectious Diseases · doi:10.1093/clinids/17.6.1018 · Cited by 150
Cell-wall glucans of Cryptococcus neoformans CAP 67
James, P. G., Cherniak, R., Jones, R. G., Stortz, C. A., & Reiss, E. (1990) · Carbohydrate Research · doi:10.1016/0008-6215(90)84273-w · Cited by 116
In vitro and in vivo anti-Candida activity and toxicology of LY121019.
Gordee, R. S., Zeckner, D. J., Ellis, L. F., Thakkar, A. L., & Howard, L. C. (1984) · The Journal of Antibiotics · doi:10.7164/antibiotics.37.1054 · Cited by 108
Bartizal, K. F., Abruzzo, G. K., Trainor, C., Krupa, D. A., Nollstadt, K. H., Schmatz, D. M., Schwartz, R., Hammond, M. L., Balkovec, J. M., & VanMiddlesworth, F. L. (1992) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.36.8.1648 · Cited by 93
Self-citationAbruzzo, G. K., Flattery, A. M., Gill, C. J., Kong, L., Smith, J. G., Krupa, D. A., Pikounis, V. B., Kropp, H., & Bartizal, K. F. (1995) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.39.5.1077 · Cited by 78
Self-citationKurtz, M., Douglas, C. M., Marrinan, J. A., Nollstadt, K. H., Onishi, J. C., Dreikorn, S., Milligan, J. A., Mandala, S., Thompson, J., & Balkovec, J. M. (1994) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.38.12.2750 · Cited by 71
Self-citationGlucan Biosynthesis in Fungi and its Inhibition
Tkacz, J. S. (1992) · Springer eBooks · doi:10.1007/978-1-4615-3274-3_19 · Cited by 40
Beaulieu, D., Tang, J., Zeckner, D. J., & Parr, T. R. (1993) · FEMS Microbiology Letters · doi:10.1111/j.1574-6968.1993.tb06088.x · Cited by 34
An ultrastructural analysis of protoplast–spheroplast induction in Cryptococcus neoformans
Peterson, E. M., Hawley, R. J., & Calderone, R. (1976) · Canadian Journal of Microbiology · doi:10.1139/m76-224 · Cited by 11
Cited by
Aspergillus fumigatus and Aspergillosis
Latgé, J.-P. (1999) · Clinical Microbiology Reviews · doi:10.1128/cmr.12.2.310 · Cited by 2,307
Comparison of Caspofungin and Amphotericin B for Invasive Candidiasis
Mora-Duarte, J., Betts, R., Rotstein, C., Colombo, A. L., Thompson-Moya, L., Smietana, J., Lupinacci, R., Sable, C., Kartsonis, N., & Perfect, J. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa021585 · Cited by 1,380
Denning, D. W. (2003) · The Lancet · doi:10.1016/s0140-6736(03)14472-8 · Cited by 1,131
Walsh, T. J., Teppler, H., Donowitz, G. R., Maertens, J. A., Baden, L. R., Dmoszynska, A., Cornely, O. A., Bourque, M. R., Lupinacci, R. J., Sable, C. A., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa040446 · Cited by 919
Candida parapsilosis, an Emerging Fungal Pathogen
Trofa, D., Gácser, A., & Nosanchuk, J. D. (2008) · Clinical Microbiology Reviews · doi:10.1128/cmr.00013-08 · Cited by 854
Metadata
- Authors
- Bartizal, K., Gill, C. J., Abruzzo, G. K., Flattery, A. M., Kong, L., Scott, P. M., Smith, J. G., Leighton, C. E., Bouffard, A., Dropinski, J. F., & Balkovec, J.
- Venue
- Antimicrobial Agents and Chemotherapy
- Publisher
- American Society for Microbiology
- Published
- 1997-11
- Volume
- 41
- Issue
- 11
- Pages
- 2326-2332
- ISSN
- 0066-4804 (ISSN-L)
- 1098-6596
- OpenAlex
- W2124458223
- Cited by
- 311
- References
- 21
- FWCI
- 10.54
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.